Zug, Switzerland

Claudia Ferrara Koller

USPTO Granted Patents = 21 

 

 

Average Co-Inventor Count = 7.9

ph-index = 9

Forward Citations = 171(Granted Patents)


Location History:

  • Schlieren, CH (2020 - 2023)
  • Zug, CH (2016 - 2024)

Company Filing History:


Years Active: 2016-2025

where 'Filed Patents' based on already Granted Patents

21 patents (USPTO):

Title: The Innovative Mind of Claudia Ferrara Koller: A Leader in Biopharmaceutical Patents

Introduction

Claudia Ferrara Koller is a prominent inventor based in Zug, Switzerland, known for her significant contributions to the field of biopharmaceuticals. With a remarkable portfolio of 20 patents, her work primarily focuses on innovative therapies for cancer treatment, enhancing the efficacy of existing medications, and developing novel therapeutic agents.

Latest Patents

Among her most recent patents, Claudia has developed notable inventions that underscore her expertise in combination therapies. One such patent involves a combination therapy with targeted 4-1BB (CD137) agonists. This invention relates to employing 4-1BB (CD137) agonists, particularly those containing antigen binding molecules, used alongside HER-2 targeting agents aimed at treating cancer. Another significant invention is her patent for bispecific antibodies specific for OX40. This innovation features new bispecific antigen binding molecules that consist of components capable of binding to target cell antigens, as well as a costimulatory TNF receptor family member. The patent also details the production methods and applications for these molecules.

Career Highlights

Throughout her career, Claudia has been associated with leading organizations in the biotech industry, notably Hoffmann-La Roche Inc. and Roche Glycart AG. Her work in these innovative companies has contributed to advancing the fields of immunotherapy and cancer treatment. Claudia's extensive knowledge and inventiveness have made her a key player in the development of transformative biopharmaceutical solutions.

Collaborations

Claudia has collaborated with esteemed professionals in her field, including Christian Klein and Pablo Umana. These partnerships have allowed her to exchange insights and foster innovations that reinforce her reputation as a distinguished inventor.

Conclusion

Claudia Ferrara Koller continues to make strides in biopharmaceutical innovation through her pioneering patents and collaborative efforts. Her dedication to developing novel therapies for cancer underscores her role as a leader in the field, paving the way for future advancements in treatment options. Her impressive record of patents reflects her commitment to improving patient outcomes and the ongoing battle against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…